A detailed history of Headlands Technologies LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 11,760 shares of GH stock, worth $256,250. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,760
Holding current value
$256,250
% of portfolio
0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$16.07 - $31.84 $188,983 - $374,438
11,760 New
11,760 $339,000
Q4 2023

Feb 02, 2024

BUY
$21.58 - $29.5 $39,793 - $54,398
1,844 Added 362.28%
2,353 $63,000
Q3 2023

Nov 09, 2023

BUY
$25.8 - $39.97 $13,132 - $20,344
509 New
509 $15,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.